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Poly(methyl methacrylate) substrates were immersed in suspensions containing bioactive
50CaO-50Si02 (mol%) glass particles (45 ~m in diameter) and a 6:4 (volume fraction) mixture of
ethanol and THF, and an ultrasonic energy was applied to the system. A layer of glass particles was
implanted and covered more than 50% of the substrate surface. Thin film X-ray diffraction patterns
and Ff-IR reflection spectra indicated deposition of apatite on the glass-implanted substrates after
they were soaked for 12 h in a simulated body fluid similar in apatite-deposition ability to the human
blood plasma. Rake-like apatite crystallites formed on the substrate soaked in SBF for 3 days.
1. INTRODUCTION
A group of materials that form a direct bond to living bones1) are called bioactive. It is essential that they can
deposit a layer of bone-like apatite. A few series of glasses and glass ceramics have exhibited bioactivity, such as
Ceravital® 2), Cerabone® A-W3), and several glasses containing CaO and Si02 including Bioglass® 4). However,
almost all of metals, ceramics and organic polymers cannot form such bonds, and they are sometimes called
biocompatible as far as they are allowed in human or mammals' bodies with forming a fibrous capsule around them.
Poly(methyl methacrylate), denoted as PMMA, is one of the most important polymers that are used in medical care.
It is thus significant if one could provide PMMA with bioactivity.
One of the present authors used an ultrasonic energy to stimulate kinetic movements of glass or ceramic powders
in suspensions and induced bombarding a substrate immersed in them5). Such ultrasonic treatment may easily
implant glass particles into any organic polymers when they are immersed in a suspension of a solvent capable of
swelling the polymers. In this respect the treatment is denoted as ultrasonic implantation. Then it is expectable that
the ultrasonic implantation of bioactive powders provides polymers with bioactivity. The present paper describes
the ultrasonic implantation into PMMA of a 50Ca0e50Si02 (mol%) glass whose bioactivity was already
confirmed6), and confirmation of the bioactivity of the glaSs-implanted PMMA substrate.
2. EXPERIMENTAL
One of the bioactive glasses of a composition 50CaO-50Si02 (mol%) was prepared by melting at 1600°C a
mixture of CaC03 and Si02 in a platinum crucible placed in a MoSi2-heated furnace and quenching the melt
between two sheets of steel. The quenched glass was annealed and pulverized with a zirconia ball mill to less than
45 Ilm in diameter. Several mixtures of ethanol and tetrahydrofurane (THF) in various fractions (volume %) were
prepared and tried as suspension media to find an appropriate mixing ratio. A sheet of PMMA (Sumitomo Chemical
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Concentration 00-3 mol/dm3)
SBF Human body plasma
142.0 142.0
5.0 5.0
2.5 2.5
1.5 1.5
147.8 103.0
4.2 27.0
1.0 1.0
0.5 0.5
Ions
Na+
K+
Ca2+
M g2+
Cl-
HC03-
HP042-
SO 2-4
Table 1. Conentrations of inorganic ions in
simulated body fluid (SBF) and the human blood
plasma.
examine the element distribution.
Co., Ltd.) was cut into pieces with 15xlOx2 mm in size. Each piece was immersed in a suspension containing up to
1 g of the glass powder dispersed in 20 or 40 ml of ethanol-THF solutions that were held in a 50 ml glass bottle.
The bottle was then immersed in an ultrasonic water bath (Iuchi Co., Pasolina USC1, 65W) and was ultrasonically
stimulated for 20 min. The temperature of the water rose from 20°C to 40°C.
A simulated body fluid (SBF) that contained inorganic components similar in concentration to the human blood
plasma7) (Table 1) was prepared after the procedure described elsewhere8), and pH was adjusted to 7.25 by 50 mM
(=10-3 mol/dm3) tris(hydroxymethyl)aminomethane and 45 mM hydrochloric acid solutions. The fluid contained
no living cel1s or organic substances. It is already confirmed that SBF produces a bone-like apatite layer that would
form in vivo on the bioactive materials9). The pieces of PMMA implanted with the glass particles were immersed in
SBF held in 50 ml polyethylene bottles wliose temperature was kept at 36.5°C. After soaking up to 7 days the
PMMA substrates were studied on their surface structure with. FT-IR reflection spectrometry and thin-film X-ray
diffractometry. The IR reflection spectra (75° off-normal)
were recorded in a JASCO FT/IR-300 spectrometer at 100
scans and 4 cm-1 resolution, using a Spectra Tech
attachment Model 501. Thin film X-ray diffraction
spectra (CuKu) were taken with a Rigaku RINT 1400
diffractometer operated under 40 kV-200mA acceleration,
at the incident angle of 1°. These two techniques give
structural information of an only about 1 j-tmthick surface
layer. A scanning electron microscope (SEM, JEOL JSM-
6300) equipped with an energy dispersive X-ray
spectrometer (Phillips, EDX-4) was used to observe
microstructure of the surfaces and cross sections and to
3. RESULTS AND DISCUSSION
Increase in the THF fraction caused a weight
loss of the specimen probably because of
chipping the swel1ed surface due to
ultrasonically stimulated glass particles. Note
that the suspensions with 30 mg glass powder
caused greater weight losses than the 500 mg
glass-suspensions and that the latter case gave
as much weight loss as the glass-free
solutions. This indicated that the implanting
rate for the 500 mg-glass suspensions was
larger than that for the 30 mg-glass ones. Fig.
2 shows SEM photographs of the cross
sections for the specimen that the ultrasonic
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Fig. 1. Weight change of the PMMA substrate after the ultrasonic
implantation as a function of the ethanol-THF mixing ratio in the
suspension medium.
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Figure 1represents weight changes of the PMMA substrate after the ultrasonic implantation as a function of the
ethanol-THF mixing ratio in the suspension medium. The amount of glass suspended was 0, 30, and 500 mg for 20
ml of the ethanol-THF solutions that were held in 30 ml glass bottles. A smal1 weight gain (1 mg) was
found irrelevant to the amount of glass until
the fraction of THF exceeded 30 vol%.
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implantation was applied to with the suspensions where 1000 mg of the glass were dispersed in 40 ml of the ethanol-
THF solutions different in mixing ratio. Energy dispersive X-ray analysis of Ca and Si distribution was also carried
out along the line indicated in the photographs. After the fraction of THF reached 40 vol%, glass particles
implanted were observable on the PMMA surface as well as the strong X-ray signals of Ca and Si. Several layers of
glass particles were implanted for the suspension of 60 vol% THF while only a layer was observable for 40 voJ%
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Fig. 2. SEM photographs of cross section of ultrasonically implanted PMMA. IOOOmg glass/40ml solution.
THFethanol= (a)7:3, (b) 6:4, (c) 5:5, (d) 4:6., Corresponding Ca and Si distributions after electron probe micro line-
analysis are also indicaated.
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THF. From those results a mixture of 6:4 ethanol-THF
Fig. 3. A SEM photograph of the surface of PMMA
after the ultrasonic implantation. looomg glass/
40mL 4THF-6ethanol solution.
solution was taken as the suspension medium where the
weight/volume ratio of the suspending glass and the media
was fixed at lOOO mg-glass/40 ml-solution.
Fig. 3 is a SEM photograph of the surface of a
specimen after the ultrasonic implantation, showing that
the glass particles implanted homogeneously cover more
than 50% of the surface. Fig. 4 shows thin-film X-ray
diffraction patterns and Fr-IR reflection spectra of the
specimen after soaking up to 7 days in SHF. The spectra
for a specimen without soaking are denoted as "Oh". A
broad X-ray diffraction for the Oh specimen near 28=300
due to the glass particles and the PMMA substrate grew in
only I h of soaking in SHF. This suggested some change
in surface structure took place on the glass surface at so
early a stage of soaking in SHF. The 12 h specimen showed faint X-ray diffraction peaks near 260 and 320 due to
the (002) plane and an envelope of (211), (112) and (300) planes of apatite (JCPDS: 9-432), respectively, and they
grew to distinct ones in a longer period of soaking. AlO30 cm-1 IR reflection peak observed for the Oh specimen
was assigned to a Si-O stretching band for the 50Ca0e50Si02 glass as well as weak 900 and 8lO cm-1 peaks. A
weaker band near 480 cm-1 was due to Si-O deformation. After 1 h soaking in SHF several bands newly appeared
at about 1240 and 1130 cm-1 that were already assigned to a longitudinal optical mode and transverse optical one of
Si-O stretchingl -4, 6,8,9) after Almeida et al. lO) For longer soaking periods, 1130 and 1040 cm-1 peaks grew in
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Fig. 4. Thin-film X-ray diffraction patterns (left) and Fr-IR reflection spectra(right) of the specimen after ultrasonic
implantation (1000 mg glass/40 mL 4THF-6ethanol solution) and soaking up to 7 days in SHF.
0: apatite,~ : Si-O optical modes.
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Fig. 5. A SEM photograph of PMMA soaked in
SBF for 3 days after ultrasonic implantation (\000
mg glass/4O mL 4THF-6ethanol solution).
4. SUMMARY
Pieces of PMMA were immersed in suspensions that
contained particles (45 !!m in diameter) of bioactive glass
of composition 5OCaa.5OSi02 in a 6:4 (volume fraction)
mixture of ethanol and THF, and an ultrasonic energy
was applied to the system. With a mixture of 40 vol% of
THF a layer of glass particles was implanted in the
surface of PMMA while several layers were implanted
for the 60 vol% THF suspension. A scanning electron
micrograph indicated that more than 50% of the surface
area were covered with the glass particles when the 40
vol% THF suspension was used for the ultrasonic
implantation. The surface structure was examined for the
specimen with glass implanted in the 6:4 ethanol-THF suspension after soaking in SBF up to 7 days. Thin film X-
ray diffraction patterns indicated trace (002) and (211) peaks of apatite for the specimen soaked for 12 h. They
became distinct in a longer period of soaking. FT-IR renection spectra showed Si-O bands before growth of apatite
lR bands. Flake-like crystallites of apatite were observed in SEM photographs for the specimen soaked in SBF for
more than I day.
intensity whereas the relative intensity of the 1240 and 1180 cm- 1 bands decreased as well as that of 900-750 cm- 1
ones until they disappeared after soaking for 7 days. Moreover, the 540 cm- 1 peak grew and finally split into two
peaks at 6\0 and 570 em-I. The 1130, 1040,6\0 and 570 cm- I peaks were due to apatite l -3 ,9). This supports the
previous assignment of the X-ray diffraction near 26° and 32° in Fig. 4.
Fig. 5 shows the SEM photograph of the specimen soaked in SBF for 3 days. Flake-like crystallites composed
hemispherical agglomerates <2 flmin diameter to cover the surface of the PMMA substrate. The morphology of the
crystallites was the same as apatite crystals found for bulk glasses and glass ceramics 1-4,6,8,9). Again deposition of
apatite was confirmed on the glass-implanted PMMA, and it was concluded that the present ultrasonic implantation
was applicable to provide PMMA with bioactivity.
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